In Europe, a national patent generally has a term of 20 years starting from the filing date. In order to at least partially compensate for the time lost to obtain a marketing authorization for a medicament...

New Rules 161 and 162 EPC, as amended by Decision of the Administrative Council CA/D 12/10 of 26.10.2010 shall apply to Euro-PCT applications for which no communication under the previously existing...

At the oral proceedings today, April 5, 2011, the Opposition Division of the EPO, in charge of opposition proceedings against European patent EP 1 220 114 of OB10, decided to fully revoke the patent...